巴陵石化的医用SEBS和SIS的加氢产品SEP、SEPS，填补了国内空白

近年来巴陵石化合成橡胶事业部突出自主创新优势，致力于调整产结构，提升产品特种化率，抢占高端市场。去年成功开发出溶聚丁苯橡胶，其性能与国际领先的朗盛公司产品媲美，自主开发的医用SEBS和SIS的加氢产品SEP、SEPS，填补了国内空白。发展建设方面，今年上半年，6万吨特种锂系聚合物装置将全面建成投产，产品特种化率进一步提升；巴陵石化合成橡胶事业部还将加快现有20万吨/年SBS装置产品结构调整，实现联产溶聚丁苯橡胶及低顺式丁二烯橡胶；抓紧建设一套2万吨/年的SEPS装置，填补国内空白，不断满足市场和客户需求。

 

Baling Petrochemical medical SEBS and SIS hydrogenation product SEP, SEPS, fill the gaps

Baling Petrochemical synthetic rubber division in recent years highlight the advantage of independent innovation, and is committed to adjust the production structure, improve product special rate, to seize the high-end market. SSBR last year's successful development of its performance with leading international the Lanxess product comparable, hydrogenation products of self-developed medical SEBS and SIS SEP, SEPS, to fill the gaps. Development of construction, the first half of this year, 60,000 tons of specialty lithium polymer device will be fully completed and put into production, the the product special rate further enhance; Division of Baling Petrochemical synthetic rubber will also accelerate the existing 200,000 t / the SBS device products structure adjust cogeneration SSBR and low-cis-butadiene rubber; the SEPS device, pay close attention to the construction of a set of 20,000 tons / year to fill the gaps, and continue to meet market and customer needs.